1	EG&G	NNP	2	nn
2	Inc.	NNP	3	nsubj
3	said	VBD	0	root
4	it	PRP	5	nsubj
5	acquired	VBD	3	ccomp
6	Laboratorium	NNP	7	nn
7	Prof.	NNP	9	nn
8	Dr.	NNP	9	nn
9	Berthold	NNP	5	dobj
10	,	,	9	punct
11	a	DT	13	det
12	German	JJ	13	amod
13	maker	NN	9	appos
14	of	IN	13	prep
15	scientific	JJ	16	amod
16	instruments	NNS	14	pobj
17	.	.	3	punct

1	Terms	NNS	4	nsubjpass
2	were	VBD	4	auxpass
3	n't	RB	4	neg
4	disclosed	VBN	0	root
5	.	.	4	punct

1	The	DT	6	det
2	Wellesley	NNP	6	dep
3	,	,	2	punct
4	Mass.	NNP	2	dep
5	,	,	2	punct
6	maker	NN	13	nsubj
7	of	IN	6	prep
8	scientific	JJ	9	amod
9	instruments	NNS	7	pobj
10	and	CC	9	cc
11	electronic	JJ	12	amod
12	parts	NNS	9	conj
13	said	VBD	0	root
14	Berthold	NNP	15	nsubj
15	expects	VBZ	13	ccomp
16	1989	CD	17	num
17	sales	NNS	15	dobj
18	of	IN	17	prep
19	more	JJR	20	mwe
20	than	IN	22	quantmod
21	100	CD	22	number
22	million	CD	24	num
23	Deutsche	FW	24	nn
24	marks	NNS	18	pobj
25	-LRB-	-LRB-	26	punct
26	$	$	24	dep
27	54.5	CD	26	number
28	million	CD	26	number
29	-RRB-	-RRB-	26	punct
30	and	CC	15	cc
31	employs	VBZ	15	conj
32	about	IN	33	quantmod
33	400	CD	34	num
34	people	NNS	31	dobj
35	.	.	13	punct

1	Berthold	NNP	3	nsubjpass
2	is	VBZ	3	auxpass
3	based	VBN	0	root
4	in	IN	3	prep
5	Wildbad	NNP	4	pobj
6	,	,	5	punct
7	West	NNP	8	nn
8	Germany	NNP	5	appos
9	,	,	5	punct
10	and	CC	3	cc
11	also	RB	12	advmod
12	has	VBZ	3	conj
13	operations	NNS	12	dobj
14	in	IN	13	prep
15	Belgium	NNP	14	pobj
16	.	.	3	punct

1	John	NNP	3	nn
2	M.	NNP	3	nn
3	Kucharski	NNP	12	nsubj
4	,	,	3	punct
5	EG&G	NNP	7	poss
6	's	POS	5	possessive
7	chairman	NN	3	appos
8	and	CC	7	cc
9	chief	JJ	10	amod
10	executive	NN	7	conj
11	,	,	3	punct
12	said	VBD	0	root
13	the	DT	14	det
14	acquisition	NN	17	nsubj
15	``	``	17	punct
16	will	MD	17	aux
17	extend	VB	12	ccomp
18	EG&G	NNP	21	poss
19	's	POS	18	possessive
20	core	NN	21	nn
21	technologies	NNS	17	dobj
22	,	,	17	punct
23	strengthen	VB	17	conj
24	its	PRP$	25	poss
25	position	NN	23	dobj
26	in	IN	25	prep
27	the	DT	30	det
28	European	NNP	30	nn
29	Economic	NNP	30	nn
30	Community	NNP	26	pobj
31	and	CC	17	cc
32	assure	VB	17	conj
33	a	DT	34	det
34	strength	NN	32	dobj
35	and	CC	34	cc
36	presence	NN	34	conj
37	in	IN	34	prep
38	the	DT	41	det
39	Eastern	JJ	41	amod
40	European	JJ	39	dep
41	market	NN	37	pobj
42	.	.	12	punct
43	''	''	12	punct

1	He	PRP	2	nsubj
2	said	VBD	0	root
3	it	PRP	6	nsubj
4	especially	RB	6	advmod
5	will	MD	6	aux
6	strengthen	VB	2	ccomp
7	the	DT	8	det
8	company	NN	10	poss
9	's	POS	8	possessive
10	efforts	NNS	6	dobj
11	in	IN	10	prep
12	the	DT	15	det
13	rapidly	RB	14	advmod
14	growing	VBG	15	amod
15	field	NN	11	pobj
16	of	IN	15	prep
17	bio-analytical	JJ	18	amod
18	instrumentation	NN	16	pobj
19	,	,	11	punct
20	and	CC	11	cc
21	in	IN	11	conj
22	applied	JJ	24	amod
23	nuclear	JJ	24	amod
24	physics	NNS	21	pobj
25	.	.	2	punct

1	Separately	RB	4	advmod
2	,	,	4	punct
3	EG&G	NNP	4	nsubj
4	said	VBD	0	root
5	it	PRP	6	nsubj
6	sold	VBD	4	ccomp
7	most	JJS	6	dobj
8	of	IN	7	prep
9	its	PRP$	13	poss
10	Mason	NNP	12	nn
11	Research	NNP	12	nn
12	Institute	NNP	13	nn
13	subsidiary	NN	8	pobj
14	to	TO	6	prep
15	Transgenic	NNP	16	nn
16	Sciences	NNPS	17	nn
17	Inc.	NNP	14	pobj
18	,	,	17	punct
19	a	DT	23	det
20	closely	RB	21	advmod
21	held	JJ	23	amod
22	biotechnology	NN	23	nn
23	company	NN	17	appos
24	based	VBN	23	partmod
25	in	IN	24	prep
26	Worcester	NNP	25	pobj
27	,	,	26	punct
28	Mass	NNP	26	appos
29	.	.	4	punct

1	The	DT	2	det
2	sale	NN	14	nsubj
3	,	,	2	punct
4	for	IN	2	prep
5	$	$	4	pobj
6	7	CD	5	number
7	million	CD	5	number
8	in	IN	5	prep
9	cash	NN	8	pobj
10	and	CC	9	cc
11	securities	NNS	9	conj
12	,	,	2	punct
13	will	MD	14	aux
14	leave	VB	25	ccomp
15	EG&G	NNP	14	dobj
16	with	IN	14	prep
17	a	DT	20	det
18	12	CD	19	number
19	%	NN	20	amod
20	stake	NN	16	pobj
21	in	IN	20	prep
22	Transgenic	NNP	21	pobj
23	,	,	25	punct
24	executives	NNS	25	nsubj
25	said	VBD	0	root
26	.	.	25	punct

1	Mason	NNP	6	nsubj
2	is	VBZ	6	cop
3	the	DT	6	det
4	largest	JJS	6	amod
5	toxicology	NN	6	nn
6	lab	NN	0	root
7	in	IN	6	prep
8	New	NNP	9	nn
9	England	NNP	7	pobj
10	,	,	6	punct
11	with	IN	6	prep
12	annual	JJ	13	amod
13	revenue	NN	11	pobj
14	of	IN	13	prep
15	$	$	14	pobj
16	8	CD	15	number
17	million	CD	15	number
18	and	CC	13	cc
19	140	CD	20	num
20	employees	NNS	13	conj
21	.	.	6	punct

1	Mason	NNP	2	nsubj
2	serves	VBZ	0	root
3	commercial	JJ	6	amod
4	and	CC	3	cc
5	government	NN	3	conj
6	customers	NNS	2	dobj
7	,	,	6	punct
8	including	VBG	6	prep
9	the	DT	11	det
10	National	NNP	11	nn
11	Institutes	NNPS	8	pobj
12	of	IN	11	prep
13	Health	NNP	12	pobj
14	.	.	2	punct

1	The	DT	3	det
2	combined	JJ	3	amod
3	companies	NNS	6	nsubj
4	will	MD	6	aux
5	become	VB	6	cop
6	profitable	JJ	11	ccomp
7	by	IN	6	prep
8	January	NNP	7	pobj
9	1990	CD	8	num
10	,	,	11	punct
11	said	VBD	0	root
12	James	NNP	14	nn
13	P.	NNP	14	nn
14	Sherblom	NNP	11	nsubj
15	,	,	14	punct
16	Transgenic	NNP	18	poss
17	's	POS	16	possessive
18	chairman	NN	14	appos
19	and	CC	18	cc
20	chief	JJ	22	amod
21	executive	NN	22	nn
22	officer	NN	18	conj
23	.	.	11	punct


